drugset / Trial / NCT02784327

A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery

NCT02784327

Phase 2 Unknown 15 enrolled PainReform LTD
NaSingle-groupOpen-labelTreatment

Summary

PRF110 is new extended release oily solution formulation of ropivacaine that is intended for local infiltration into surgical wounds. The purpose of this study is to determine the safety and early efficacy of PRF110 in bunionectomy surgery, to measure the pharmacokinetic profile of PRF110 over 72 hours and evaluate the duration of analgesia witnessed in the surgical setting.

Timeline

Start
2016-08
Primary completion
2017-04
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified Other

Indications

No indication recorded.